Join our mailing list to receive the latest updates and alerts Flag Subscribe

Fredrikson & Byron acted as legal counsel to Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, in its acquisition of Zephyrus Biosciences, Inc. Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne. Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Fredrikson’s legal team was led by Joseph J. Schauer, Ryan C. Brauer and Andrew M. Nick.

Read the news release.

Jump to Page

Fredrikson & Byron, P.A. stores cookies on your device to enhance site navigation, make your browsing experience as useful as possible, and analyze site usage. By accessing this website with cookies enabled in your web browser, you agree to the storing of cookies on your device. Please read our Privacy Policy and our Disclaimer.